US Bancorp’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$80.5K Buy
10,501
+8,501
+425% +$58.2K ﹤0.01% 2495
2025
Q4
$3.96K Hold
2,000
﹤0.01% 3613
2025
Q3
$4.92K Hold
2,000
﹤0.01% 3549
2025
Q2
$5.28K Sell
2,000
-791
-28% -$2.13K ﹤0.01% 3619
2025
Q1
$8.4K Buy
+2,791
New +$8.46K ﹤0.01% 3496
2023
Q4
Sell
-1,710
Closed -$2.89K 4054
2023
Q3
$2.89K Hold
1,710
﹤0.01% 3583
2023
Q2
$4.75K Buy
1,710
+487
+40% +$1.38K ﹤0.01% 3491
2023
Q1
$2.23K Buy
1,223
+87
+8% +$271 ﹤0.01% 3733
2022
Q4
$5.76K Buy
1,136
+812
+251% +$4.46K ﹤0.01% 3467
2022
Q3
$2K Hold
324
﹤0.01% 3834
2022
Q2
$1K Hold
324
﹤0.01% 3961
2022
Q1
$2K Sell
324
-262
-45% -$1.61K ﹤0.01% 3830
2021
Q4
$4K Sell
586
-2,000
-77% -$15K ﹤0.01% 3713
2021
Q3
$25K Sell
2,586
-1,398
-35% -$15.4K ﹤0.01% 3013
2021
Q2
$57K Hold
3,984
﹤0.01% 2612
2021
Q1
$95K Hold
3,984
﹤0.01% 2300
2020
Q4
$53K Buy
3,984
+984
+33% +$9.46K ﹤0.01% 2491
2020
Q3
$21K Sell
3,000
-2,000
-40% -$19.9K ﹤0.01% 2798
2020
Q2
$61K Buy
5,000
+3,000
+150% +$16.9K ﹤0.01% 2341
2020
Q1
$6K Buy
+2,000
New +$10K ﹤0.01% 3189

Other funds holding IBRX